China Curbs Drug Promotion Claims

21 May 1995

China has issued new controls banning the promotion of drugs that claim to treat mental illness, drug addiction, tumors, AIDS and sexual dysfunction, and commercials for birth control drugs. Narcotics, vaccines, poisonous or radioactive drugs and birth control drugs may not be advertised.

Phrases such as "the best," "latest technology" or "without side effects" may not be used in any promotional material. Endorsements by research bodies, experts, doctors or patients are also forbidden, and advertisements may not refer to efficiency rates or awards. Images of children may not be used, and ads cannot describe symptoms of a disease in such a way as to suggest to non-sufferers that they have acquired it, nor imply that a disease will worsen if an advertised drug is not used.

All drug advertising must be submitted to the Health Ministry or provincial authorities for approval. A reassessment of drug advertisements in major national media outlets will start on June 1.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight